Ramsay Stattman Vela & Price’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-2,563
Closed -$230K – 84
2022
Q2
$230K Hold
2,563
– – 0.05% 87
2022
Q1
$284K Hold
2,563
– – 0.06% 87
2021
Q4
$265K Hold
2,563
– – 0.06% 64
2021
Q3
$321K Hold
2,563
– – 0.08% 61
2021
Q2
$318K Hold
2,563
– – 0.08% 62
2021
Q1
$303K Hold
2,563
– – 0.08% 63
2020
Q4
$300K Hold
2,563
– – 0.08% 61
2020
Q3
$266K Hold
2,563
– – 0.08% 60
2020
Q2
$235K Hold
2,563
– – 0.08% 61
2020
Q1
$231K Buy
2,563
+675
+36% +$71.8K 0.09% 57
2019
Q4
$214K Hold
1,888
– – 0.07% 62
2019
Q3
$205K Buy
+1,888
New +$197K 0.07% 59

Other funds holding MDT

Ramsay Stattman Vela & Price's MDT Position: Q3 2022 in Review

Ramsay Stattman Vela & Price sold out of Medtronic (MDT) in Q3 2022, closing a stake of 2,563 shares — an estimated $230K sold.

Ramsay Stattman Vela & Price first reported a position in MDT in Q3 2019 and held it in 12 quarters. The position peaked at $321K in Q3 2021. 1,931 funds tracked by Wall St. Rank hold MDT as of Q3 2022.

  • Ramsay Stattman Vela & Price reported no remaining Medtronic position as of Q3 2022 after selling out during the quarter.
  • Ramsay Stattman Vela & Price sold 2,563 Medtronic shares in Q3 2022, an estimated $230K.
  • Ramsay Stattman Vela & Price first reported a position in Medtronic in Q3 2019 and held it in 12 quarters.
  • Ramsay Stattman Vela & Price's Medtronic position peaked at $321K in Q3 2021.
  • 1,931 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.

Based on Ramsay Stattman Vela & Price's 13F filing for Q3 2022, filed 31 Oct 2022.